PARIS — The European Society of Cardiology released five new guidelines, which introduce fresh recommendations such as an LDL goal of less than 55 mg/dL in patients at very high risk for CVD and the use of SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes requiring CVD prevention.
The guidelines, which also include recommendations on management of chronic coronary syndromes, pulmonary embolism and surpraventricular tachycardia, were released at the ESC Congress and published in the European Heart Journal.
The new ESC guideline on
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life. Yes, it is to make people understand that the conventional method of treating T2DM is not beneficial. The best way to reverse and fight T2DM is through diet and lifestyle modification. He decided to help people suffering from T2DM in their new journey by offering consultations and working together with them in order to achieve a T2DM free life.